Portfolio company
PacingCure
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops precision gene therapies and biological pacemakers for patients suffering from cardiac rhythm disorders and heart failure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cardurion Pharmaceuticals
This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.
Tenaya
This biotechnology company develops gene therapies and precision medicines for patients suffering from heart disease and rare genetic cardiac conditions.
Cardior
This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.
Marea Therapeutics
This biotechnology company develops medicines for cardiometabolic and cardioendocrine diseases using human genetic data for patients with unmet medical needs.
Cardurion
The company develops novel therapeutic treatments for patients with heart failure and other cardiovascular diseases.
Ceryx Medical
This company develops bioelectronic medical devices and pacing technology to treat patients with heart failure, hypertension and neurological injuries.
Acesion Pharma ApS
This biotech company develops small-molecule drugs to treat atrial fibrillation by inhibiting ion channels for patients with cardiac arrhythmia.
Maxwellbiomedical
This company develops an electrical stimulation platform for patients with atrial fibrillation to restore heart rhythms and function without destroying tissue.
